Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
knowledge of English and you must be able to present documentation that proves that you have: experience in reinforcement learning experience in agent-based modelling and simulation ability to work
-
disease research. Mentor and project matches will be based upon your academic experience and professional interests. At the end of your internship you will be expected to prepare a slide presentation based
-
learning with knowledge-based inference, validated by independent experiments and partially supervised by human-in-the-loop systems. A key question will be how agentic AI and foundation models can be
-
will teach and mentor students and collaborate to develop courses that integrate AI into research and curricula in their respective fields. The tenure home will be based on the successful candidate’s
-
if you have experience with safety-critical systems, multi-agent autonomy, or learning-based/data-driven/robust/adaptive control under uncertainty, supported by strong mathematical foundations. Hands
-
. • Familiarity with MODFLOW, MATPOWER, OpenDSS, Machine Learning based emulators, or agent-based modeling. • Knowledge of scenario development, resilience frameworks, and socio-environmental-technological systems
-
progressed capabilities towards exploiting zero-day vulnerabilities. Frontier models show promising performance when combined with a focused knowledge base and multi-agent architectures. However, in most cases
-
funding availability. What are the provisions? You will receive a stipend to be determined by MRICD. Stipends are typically based on a participant’s academic standing, discipline, experience, and research
-
infrastructure systems such as power, water, sewer, and communications systems. It introduces existing physics-based modeling of these systems. It then covers the main tools used to simulate, optimize, and analyze
-
Instituto de Investigação e Inovação em Saúde da Universidade do Porto (i3S) | Portugal | 3 months ago
combination with immune checkpoint inhibitors, and determine the impact of combination therapy versus each agent alone on lymphoma growth. Since anthracycline chemotherapeutic drugs can induce immunogenic cell